Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

INTRODUCTION: Currently, 15–20% of individuals with coronary artery disease (chronic coronary syndrome [CCS]) or peripheral artery disease (PAD) receiving routine treatment experience cardiovascular events (CVEs) within 3–4 years. Using PICOSTEPS (Patients-Intervention-Comparators-Outcomes-Setting-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Soini, Erkki, Virtanen, Outi, Väätäinen, Saku, Briere, Jean-Baptiste, Bowrin, Kevin, Millier, Aurelie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467417/
https://www.ncbi.nlm.nih.gov/pubmed/32519113
http://dx.doi.org/10.1007/s12325-020-01398-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467417/
https://www.ncbi.nlm.nih.gov/pubmed/32519113
http://dx.doi.org/10.1007/s12325-020-01398-8

Ejemplares similares